MCL1 and cancer: To identify putative genomic biomarkers of MCL1 sensitivity, we interrogated MCL1 gene dependency data from genome wide CRISPR/Cas9 cell viability screens using the Broad Institute’s Cancer Dependency Map (DepMap) (10, 11).